Skip to content

Clinical precise positioning study of salvianolic acid for injection in the treatment of acute ischemic cerebrovascular disease: a multi-center, single-arm, open clinical program

Clinical precise positioning study of salvianolic acid for injection in the treatment of acute ischemic cerebrovascular disease: a multi-center, single-arm, open clinical program

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200055219
Enrollment
Unknown
Registered
2022-01-03
Start date
2022-01-03
Completion date
Unknown
Last updated
2023-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute Ischemic stroke

Interventions

Sponsors

The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Diagnosed as ischemic stroke with onset time = 18 years, gender is not limited; 4. Those with first-time onset; or those with a history of onset, no sequelae such as limb paralysis, and no impact on the NIHSS score, and mRS score <= 1; 5. Voluntarily sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Brain tumor, encephalitis, brain abscess and other diseases that cause similar symptoms are confirmed by head imaging examination, or hemorrhagic stroke, epidural hematoma, intracranial hematoma, intraventricular hemorrhage, subarachnoid hemorrhage, etc.; 2. Severe disturbance of consciousness (NIHSS Ia item >= 2 points); 3. Those who are allergic to the drug ingredients used in the study; 4. Patients with serious heart, liver, kidney, blood diseases, endocrine system and other serious primary diseases; 5. Pregnant and lactating patients; 6. Drug or alcohol abusers; 7. Patients with mental illness; 8. Those who are participating in or have participated in other clinical trials within one month; 9. Patients deemed unsuitable for inclusion by the investigator.

Design outcomes

Primary

MeasureTime frame
Modified Rankin Scale;

Secondary

MeasureTime frame
National Institutes of Health Stroke Scale;Barthel Index;Mini-Mental State Examination Scale;The incidence of postoperative major cardiovascular and cerebrovascular events (MACCE);The incidence of apoplexy-related complications;Metabonomics;

Countries

China

Contacts

Public ContactXu Qiang
tcmxuqiang@hotmail.com+86 22 60637959

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026